NLRP3 inflammasome activation and symptom burden in KRAS-mutated CMML patients is reverted by IL-1 blocking therapy
暂无分享，去创建一个
J. Hernández-Rivas | T. Chen-Liang | H. Martínez-Banaclocha | P. Pelegrín | E. Such | Laura Hurtado-Navarro | R. Teruel-Montoya | G. Carreño-Tarragona | F. Ferrer-Marín | C. García-Palenciano | Ernesto José Cuenca-Zamora | Beatriz Bellosillo | María Luz Morales | M. L. Lozano | L. Zamora | Eva Soler-Espejo | Javier Marco-Ayala | Laura Martínez-Alarcón | Lola Linares-Latorre | Sara García-Ávila | Paula Amat-Martínez | Teresa González | Montserrat Arnan | Helena Pomares-Marín | María T. Herranz | Andrés Jerez